DK0901790T3 - Anvendelse af moxonidin til behandling af neuropatisk smerte - Google Patents

Anvendelse af moxonidin til behandling af neuropatisk smerte

Info

Publication number
DK0901790T3
DK0901790T3 DK98117344T DK98117344T DK0901790T3 DK 0901790 T3 DK0901790 T3 DK 0901790T3 DK 98117344 T DK98117344 T DK 98117344T DK 98117344 T DK98117344 T DK 98117344T DK 0901790 T3 DK0901790 T3 DK 0901790T3
Authority
DK
Denmark
Prior art keywords
moxonidine
treatment
neuropathic pain
composition
pharmaceutically acceptable
Prior art date
Application number
DK98117344T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Tinna M Laughlin
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK0901790T3 publication Critical patent/DK0901790T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98117344T 1997-09-16 1998-09-14 Anvendelse af moxonidin til behandling af neuropatisk smerte DK0901790T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5902197P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
DK0901790T3 true DK0901790T3 (da) 2001-08-06

Family

ID=22020310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98117344T DK0901790T3 (da) 1997-09-16 1998-09-14 Anvendelse af moxonidin til behandling af neuropatisk smerte

Country Status (8)

Country Link
US (1) US6054461A (da)
EP (1) EP0901790B1 (da)
AT (1) ATE201598T1 (da)
DE (1) DE69800859T2 (da)
DK (1) DK0901790T3 (da)
ES (1) ES2157107T3 (da)
GR (1) GR3036071T3 (da)
PT (1) PT901790E (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
DE19911371A1 (de) * 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
US7015371B2 (en) * 2001-03-07 2006-03-21 Mary Hannaman Romans Non-traumatic model for neurogenic pain
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
CA2487541A1 (en) * 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
NZ541008A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
US20040175423A1 (en) * 2003-02-05 2004-09-09 Daniella Licht Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds
AU2004229551A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
PL1962836T3 (pl) * 2005-11-08 2011-06-30 Arcion Therapeutics Inc Leczenie neuropatii zależnej od długości aksonów
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US7964585B2 (en) * 2006-03-14 2011-06-21 Case Western Reserve University Composition and method of treating peripheral neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06507392A (ja) * 1991-02-26 1994-08-25 エイアールシー　１，インコーポレイテッド 交感神経性の持続性疼痛の治療のための組成物および方法

Also Published As

Publication number Publication date
GR3036071T3 (en) 2001-09-28
EP0901790B1 (en) 2001-05-30
US6054461A (en) 2000-04-25
DE69800859T2 (de) 2001-09-27
DE69800859D1 (de) 2001-07-05
ATE201598T1 (de) 2001-06-15
PT901790E (pt) 2001-09-28
EP0901790A1 (en) 1999-03-17
ES2157107T3 (es) 2001-08-01

Similar Documents

Publication Publication Date Title
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
MY119403A (en) Novel compounds with analgesic effect.
PL309594A1 (en) Apllication of rilusole in treating parkinson disease and parkinsonian syndromes
HK1003978A1 (en) Composition for the treatment of schizophrenia
IL108844A0 (en) Use of riluzole in the reatment of neuro-aids
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
FI971127A0 (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
MY136449A (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
WO2001085188A3 (en) Use of echinacea as a hematinic agent
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
MY118982A (en) Method of reducing tissue damage associated with ischemia
ZA9427B (en) Use of riluzole for promoting restoration following radiation
NZ508292A (en) Treatment of migraine symptoms with ibuprofen and salts thereof
MD1469G2 (ro) Metodă de tratament al şocului combustional
MX9801680A (es) Derivado de fenil pirimidina opticamente activo como agente analgesico.
MX9804798A (es) Nuevos compuestos con efecto analgesico.